Hims Hers Health (HIMS) Superinvestor holders
11 of the superinvestors we track hold Hims Hers Health (HIMS) in their latest 13F filings, $219M in total.
Summary
The largest holder is Paul Marshall (Marshall Wace), with $146M, 0.1% of the portfolio.
In their latest quarter: 2 opened a new position, 5 added, 3 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Paul Marshall Marshall Wace |
Added | 4,217,767 | $146M | 0.1% | Q2 2026 |
| Baillie Gifford Baillie Gifford & Co |
Added | 794,827 | $24M | 0.0% | Q3 2026 |
| Mark Kingdon Kingdon Capital Management |
New position | 542,500 | $19M | 2.5% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 210,084 | $7M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 171,530 | $6M | 0.0% | Q2 2026 |
| Tony Yoseloff Davidson Kempner Capital Management |
Held | 160,012 | $6M | 0.1% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 128,796 | $4M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Added | 118,383 | $4M | 0.0% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 38,962 | $1M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 38,148 | $1M | 0.0% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 7,036 | $243,938 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 11 |
| Q1 2026 | 12 |
| Q4 2025 | 14 |
| Q3 2025 | 15 |
| Q2 2025 | 17 |
| Q1 2025 | 14 |
| Q4 2024 | 14 |
| Q3 2024 | 16 |
Questions about Hims Hers Health
Which superinvestors own Hims Hers Health?
11 of the superinvestors we track hold Hims Hers Health (HIMS) in their latest 13F filings, $219M in total. Paul Marshall, Baillie Gifford, Mark Kingdon, Cliff Asness, David Shaw, Tony Yoseloff.
Who is the largest superinvestor holder of HIMS?
The largest holder is Paul Marshall (Marshall Wace), with $146M, 0.1% of the portfolio.
From Hims Hers Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.